Reacción #359271

ord-654423ce16344b95b39d50fcd0af939a

Condiciones de reacción

Condiciones detalladas
See reaction.notes.procedure_details.

Tratamiento posterior

  1. 1
    OtroThe solvent in the reaction liquid
  2. 2
    workup.DISTILLATIONwas distilled off under reduced pressure
  3. 3
    Otrothe resulting residue was purified by preparative thin-layer chromatography (aluminium oxide 60F254, Art. 5713 (Merck), choroform/methanol=18/1)

Procedimiento

To 15 mg of (2R)-1-{(2S,4R)-4-hydroxy-1-(3,3,3-triphenylpropanoyl)pyrrolidin-2-yl}carbonyl-N-{((3S)-1-methyl-3-piperidyl)methyl}pyrrolidine-2-carboxamide, 0.5 ml of 10% methyl bromide-acetonitrile was added at room temperature, followed by 12 hours' stirring. The solvent in the reaction liquid was distilled off under reduced pressure, and the resulting residue was purified by preparative thin-layer chromatography (aluminium oxide 60F254, Art. 5713 (Merck), choroform/methanol=18/1) to provide 15 mg of the title compound as a white solid.

Fuente

DOI: 10.6084/m9.figshare.5104873.v1Patente: US07452908B2uspto-grants-2008_11